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Abstract
Vaccination is regarded by many as the most effective means of reducing influenza
infection and disease; however, many people in the United States are hospitalized from
flu-related illness each year. Adults 65 years and older account for more than half of
these hospitalizations and almost all flu-related deaths. This project aimed to identify
barriers to receiving the influenza vaccine among the adult population (> 65 years of age)
in a community setting. The goal was to develop a teaching tool that would assist
practitioners towards improving influenza vaccination rates among this population. The
Health Belief Model was the theoretical framework utilized. The project was conducted
at a primary care practice located in a community outside of New York City. Fifty
participants (> 65 years) with no prior influenza vaccination were invited to take part in a
short survey involving immunization status and reason for lack of influenza vaccination.
Participants completed a researcher designed survey in a private location within the
practice setting. Descriptive analysis was completed. Results revealed that 45 (32 females
and 13 males) participants refused the influenza vaccine based on fear of becoming
infected with the flu from the vaccine itself. The remaining 5 (males) participants based
their refusal on never having the flu and therefore deemed the vaccine unnecessary. An
educational handout was developed to aid in patient education related to influenza
vaccination. Future implications involve the utilization of this tool by all healthcare
worker and providers, as well as educating the target population in all community settings
where influenza vaccines are administered, ultimately reducing the incidences of
influenza and its associated complications by overcoming barriers to vaccination.
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Section 1: Nature of the Project
Introduction
The inﬂuenza (flu) vaccine is widely regarded as being underutilized despite
current recommendations. A common anecdotal complaint about the annual flu vaccine
is that it is ineffective because patients are infected with the flu virus despite receiving
the vaccination. Epidemiological data seem to back up such anecdotes (Sanghavi, 2012).
According to an American Lung Association report from 2010, over the past decades, no
sustained decline in influenza-associated deaths were noted. Hospitalization rates among
those 65 years and older rose gradually between 1979 and 2001, even though there was
an increase in influenza vaccination rates among this age group from 32% in 1989 to
67% in 1997 (Glezen, 2008). Reports of data such as this may make the influenza
vaccine seem useless. As a result, skepticism has lately moved beyond the usual
antivaccine crowd, and barriers to receiving the flu vaccine occur.
Problem Statement
There are potential barriers to receiving the seasonal influenza vaccine for adults
in the community 65 years and older.
Purpose Statement and Project Objectives
The goal of this project was to identify barriers to receiving the influenza vaccine
among the 65 and older population in a community setting and propose interventions to
eliminate unnecessary barriers. Development of new and more effective influenza
vaccines are warranted as evidence for protection by influenza vaccines in adults older
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than 65 years old are lacking because researchers are currently working on acquiring the
next generation of influenza vaccines (Finnegan, 2014).
Decreasing the mortality problem of influenza within the 65 years and older
population was noted by the placement of influenza vaccination policies in high-income
countries (Simonsen, L., Taylor, R., Viboud, C., Miller, M., & Jackson, L., 2007). One
main goal of Healthy People 2020 (2014) is to enlarge the number or children and adults
vaccinated annually for seasonal influenza. The elderly population, particularly those at
least 70 years old, makes up three-quarters of influenza related deaths, and yet few
placebo-controlled randomized trials have included this population (Simonsen et al.,
2007). Within the subspecialty area of adult health in primary care, the issue of to
vaccinate or not to vaccinate against the flu is ongoing, and many potential barriers
towards receiving the influenza vaccine exist. Practitioners are often questioned on the
subject by patients, not only the nurse practitioner, when prescribing but also as a staff
RN’s and clinical instructors in regards to administering and teaching about the flu
vaccine. However, because the geriatric population is a high risk group and is often seen
in the primary care setting, defining and analyzing potential barriers is an important issue
to research and review.
Research on knowledge translation adds clarity to the phases of moving research
evidence into clinical practice (White & Dudley-Brown, 2012). To investigate potential
barriers to receiving the influenza vaccine, this project involved discussing reasons why
adult patients belonging to a primary care practice in a specific community in New York
City are refusing the influenza vaccine. Patients of the practice who met the
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requirements were identified through their refusal of the vaccine and their age of 65 years
and older. After giving verbal consent, barriers were discussed and documented.
Potential barriers towards influenza vaccination were evaluated through
discussion and questions pertaining to participants’ interests in and use of the flu vaccine,
their understanding of the risks and benefits of the vaccine, and their opinions regarding
common reasons for vaccine refusal. Other pieces of information were also collected
from respondents including age, sex, race/ethnicity, and primary language. Their
participation was completely anonymous and did not require any personally identifiable
information. Once participants completed their responses, the information was collected
and reviewed. After reviewing the information collected, an educational module was
developed and implemented within the primary care practice for patient and provider
education.
Significance/Relevance to Practice
In order to decrease the negative consequences of influenza and obtain the goals
of Healthy People of 2020, considerable improvements regarding the annual influenza are
needed (CDC, 2014). Numerous data sources are employed by the CDC in order to
acquire estimations of influenza vaccination coverage related information that may guide
programs and policies for improved choices on coverage related issues (CDC, 2014). In
place of the influenza vaccination, there is no solitary data source that specifies estimates
of season-specific influenza vaccination coverage, according to the CDC. For the 2011–
12 influenza season, vaccination implementation differed by several factors including
state, age group, and selected populations (CDC, 2014). With a goal of 70% for ages 6
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months to 17 years old, 70% for ≥18 years, and 90% for HCP, it was noted that coverage
approximates fell below this objective set forth by Healthy People 2020 (CDC, 2014).
Even though influenza vaccination coverage was higher in the age group of adults greater
than 65 years old, it has not increased over the past 5 seasons since 2012 (CDC, 2014).
Primary care practice involves all ages of patients, all socioeconomic and geographic
origins, and patients who are seeking to maintain optimal health. These patients also
encompass acute and chronic physical, mental, and social health issues, often with
multiple chronic diseases. Providers have an important role in health promotion
involving all levels of care including primary, secondary, and tertiary. This involves
approaches to engage and improve patients’ overall health status and include them in
their own health issues, concerns, decisions, and prevention.
Project Question
For patients 65 years and older, what are potential barriers to receiving the
influenza vaccine?
Evidence-Based Significance of the Project
As reported by the CDC (2009), it is estimated that more than 200,000 people in
the United States are hospitalized each year from flu-related illness. The CDC has also
reported that of these confirmed hospitalizations, adults 65 years and older typically
account for more than half (60%) and almost all (90%) flu-related deaths. Because adults
aged 65 years and older have a higher incidence or mortality combined with aggravating
preexisting medical conditions, this hospitalization rate is related to an overall impaired
immune response (Simonsen et al., 2007). It can then be presumed that the influenza
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virus in older adults creates a burden not only on the individual but also on society and
healthcare services.
The CDC (2008) has reported that vaccination is deemed the most effective
method of decreasing influenza rates among all age groups. Moreover, according to the
CDC, influenza continues as a worldwide contributor to human suffering and financial
burden despite influenza vaccination recommendations and programs used to target highrisk individuals. It can be easily noted that although the influenza virus affects people of
all ages, it is the older adults, young children, and those afflicted by chronic diseases and
weakened immune systems who bear the burden of increased mortality and morbidity
rates (WHO, 2005). An increased risk of hospital admissions diagnosed with pneumonia
and influenza were noted among community residences with older adults, especially
during an influenza epidemic (Hak et al., 2004). As a result of such notations, adults 65
years and older are considered to be at a higher risk for serious influenza illnesses (CDC,
2008).
Adults 65 years and older display higher mortality rates for infectious diseases
than those compared with people younger and with the same infection (Yoshikawa,
2000). Studies have shown that adults 65 years and older comprise 90% of the total
number of deaths, and the chance of death rises among this age group when underlying
chronic diseases are present (Thompson et al., 2003). Because influenza causes a decline
in overall health status, especially among older adults, it can often produce or exacerbate
preexisting disabilities (McElhaney, 2005). According to Healthy People 2020, the
eighth leading cause of death in the United States is comprised of acute respiratory
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infections, which account for 56,000 deaths annually. More than 200,000
hospitalizations and 36,000 deaths occur each year from these acute respiratory illnesses
as well. In 2009, the H1N1 influenza pandemic affected and hospitalized an estimated
270,000 people, and, as a result, 12,270 deaths were reported (Healthy People 2020,
2014).
Brown, Goebel, Neitch, Tweel and Mufson (2011) assessed the regularity of
influenza vaccine among 3,858 older adults as well as their most common barriers to
receiving the vaccine. The results analyzed the implementation of seasonal and H1N1
vaccines among adults 65 years and older with their university practice and surveyed a
cohort of 64 patients to determine whether they had accepted the H1N1 vaccine and their
reasons for refusal (Brown et al., 2011). Among this population, acceptance rates of
seasonal influenza vaccine were low, and a substantial proportion did not receive the
H1N1 vaccine because it was not clear whether they should receive it (Brown et al.,
2011).
Implications for Social Change in Practice
It has been noted among governing bodies and health care providers that the
annual influenza vaccine is recommended to targeted age groups for prevention of
influenza, yet these persons at risk still refuse. As a healthcare provider, it is only normal
to question and investigate the reasons why. Behavior regarding this issue among the
adult population of 65 years and older is nominally researched. Related information
taking the place of vaccination against influenza and associated concerns does not exist in
one single data source (CDC, 2014). However, vaccines remain among one of the most
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cost-effective medical preventive services. Currently, in the United States, nearly 42,000
adults and 300 children die yearly from vaccine preventable diseases (Healthy People
2020, 2014).
Assumptions and Limitations
It is assumed that within a study, some factors are out of my control. For
example, it was assumed that participants of this survey answered honestly. It was
conveyed that the participants were volunteers and may withdraw from the survey at any
time with no ramifications. Since it was impossible to include every adult over the age of
65 within the community, it was assumed that the sample was representative of the
chosen patient population. It was also presumed that potential weaknesses of this project
were out of my control, as there are limitations in everything. Therefore, the results of
the survey can generally be suggested to a larger population. Furthermore, the
information collected from the survey is only as good as the survey itself. The survey
was also dependent on conditions occurring during that time since it was conducted over
a certain interval of time. Other limitations to mention include time constraints,
willingness to participate, and number of participants involved.
Summary
Patients regularly give reasons why they believe they should not have a flu
vaccination. Nonetheless, influenza vaccines substantially diminish mortality, morbidity,
and deteriorating disabilities involving older adults while remaining cost effective.
Within the general specialty area of adult health in primary care, the issue of to vaccinate
or not to vaccinate against the flu is ongoing, and many potential barriers towards

8
receiving the influenza vaccine exist. There are a number of possible factors influencing
why eligible individuals do not receive protection against influenza. Patient knowledge,
patient perception, patient values, social influences, approach to care, health care
provider attitudes, medical office systems, and fear of getting ill from the vaccine are all
possible factors influencing why individuals refuse the influenza vaccine. Equivocal
education involving patients, physicians, and communities are needed to reach high rates
of influenza vaccination among the older adult population. In the present day, no one
should die from influenza resulting from refusal to vaccinate.
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Section 2: Review of Literature and Theoretical and Conceptual Framework
Specific Literature
According to the CDC, medical office visits have been reduced by nearly 60% as
a result of the seasonal vaccination for the 2013–14 season, indicating the benefits of the
influenza vaccine. Additionally, for the 2013-14 influenza season, roughly 134 million
doses of influenza vaccine had been dispersed in the United States, as of February 8,
2014 (CDC, 2014). The best strategy for preventing influenza continues to be yearly
vaccination. However, despite this information, people still remain unvaccinated for
personal reasons.
One Canadian study was designed and conducted with the objective of exploring
the self-perceived influences among older Canadian adults in deciding whether to take or
not take the seasonal influenza vaccine (McIntyre et al., 2014). They employed a
qualitative cross-sectional design with focus groups as the method of data collection.
Eleven males and 26 females (n = 37) took part in six focus groups conducted at five
locations (four retirement homes and one condominium building) between August and
November 2010. The average age of participants was 82 years (SD = 6.6, range: 67–91
years). The study inclusion criteria included living in the community without extensive
assistance with activities of daily living, being over age 65, and being fluent in English.
The researchers had no previous contact and no relationship with participants (McIntyre,
2014).
Participants provided information about their experiences and described factors
that influenced their decision-making process regarding vaccine receipt. Content analysis
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produced 15 codes from which five overarching themes emerged. The five themes were
moderators, beliefs, prevention, accessibility, and knowledge. Moderators and beliefs
were the two most influential themes, while prevention, accessibility, and knowledge
played smaller roles in the decision-making process (McIntyre et al., 2014). The most
influential decision-making factor for receivers in this study was the recommendation by
a general practitioner (GP; McIntyre et al., 2014). This suggests the crucial influence of
GP prompts in the decision-making process. The patient-physician relationship ought to
be built on trust, respect, and knowledge. The stronger the relationship, the more likely a
patient would be willing to take a physician’s advice on all health aspects, including
preventive health measures (McIntyre et al., 2014).
Findings from this survey have a potential to better inform public health policy
makers about specific factors that influence the decision-making process of older adults
regarding preventive health behaviors: in particular, receipt of influenza vaccine
(McIntyre et al., 2014). Future initiatives to improve vaccine intake should consider the
powerful role of the physician, a need for greater knowledge about influenza, how the
vaccine works, and education about adverse events. McIntyre et al. (2014) also proposed
a model that chronologically orders the factors that influence the decision-making
process of older adults for the receipt of the influenza vaccine. They also implied that
future research should be longitudinal in nature and should involve a larger number of
participants (McIntyre et al., 2014).
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General Literature
Flu pandemics have occurred throughout history. There have been four since
1918, each with different characteristics. The first initiation of live attenuated vaccines
began with the isolation of the influenza virus 80 years ago (Hannoun, 2013). However,
the first inactivated influenza vaccine, Influenza A, was noted to be monovalent. A
bivalent vaccine was then developed, in 1942, after the detection of Influenza B.
Following these findings, the influenza virus was noted to be mutating and leading to
antigenic changes (Hannoun, 2013). The WHO has published yearly endorsements for
the structure of the influenza vaccine centered on results from surveillance systems that
isolate currently circulating strains. The first trivalent vaccine, which included two
Influenza A strains and one Influenza B strain, were developed in 1978. Currently, there
are only two Influenza B lineages in circulation (Hannoun, 2013).
In order to analyze reasons why adults 35 years and older were not receiving the
influenza vaccine, the Medicare Current Beneficiaries was initiated (CDC, 2009).
Approximately 20% of patients cited that the reason they were not vaccinated was
because they did not know they needed the vaccine, while a small number of patients
stated their concerns of getting ill from the vaccine itself (CDC, 2009). Additionally,
13.7% of patients were afraid of unfavorable effects of the influenza vaccine. There were
minimal concerns about the cost of the vaccine, which was reported by less than 1% of
patients responding (CDC, 2009).
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Conceptual Models/Theoretical Framework
The health belief model (HBM) offers a theoretical framework used for
measuring the probability that an individual will take advantage of offers provided within
their health services (Nexoel et al., 1998). According to the model, people will take steps
to avoid diseases if they believe that they are directly susceptible, that the incidence of
the disease will have a moderate impact on some aspect of life, that taking a certain
action will be beneﬁcial in decreasing their predisposition to the condition, and that their
action does not involve overcoming essential barriers (Nexoel, 1998). Therefore, the
HBM was employed to measure the probability that an individual will accept or decline
the flu vaccine and possible reasons why.
There are four critical areas that the HBM suggests a person's health-related
behavior and perceptions depends on: the gravity of a possible illness, the person's
susceptibility to that illness, the advantages of taking a preventative action, and the
obstacles to taking that action (Nursing Theories, 2013). Regarding issues centering on
patient compliance and preventative practices the HBM is a useful model applied,
especially in nursing (Nursing Theories, 2013). This model focuses on the relationships
between an individual’s beliefs and behaviors and offers a way to understand and predict
how patients will behave relative to their health and how they will comply with therapies
in health care.
There are six major concepts in HBM, starting with perceived susceptibility. This
is the person's view of how severely they would be impacted if they were affected by the
condition. In perceived severity, only when the patient perceives a high enough severity
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for serious complications to occur with action occur. The patient’s belief in a given
treatment that will cure or prevent an illness occurs in perceived benefits. The patient will
then realize the difficulty, duration, and convenience of treatment with perceived costs.
The desire to conform to a treatment by the patient is seen during motivation. Lastly,
with modifying factors, the patient’s personality variables, satisfaction, and
sociodemographic factors can be seen. Therefore, health seeking behaviors may be
influenced by an individual’s perception of a danger posed by a health issue and the
importance associated with acts aimed at decreasing the danger (Nursing Theories, 2013).
In order to effectively overcome barriers to increase vaccine acceptance, several
strategies have been noted (Stinchfield, 2008). Two of the most effective strategies are
convincing provider recommendations towards immunization and standing orders that
allow nurses and other qualified personnel to initiate and provide vaccination, if
indicated, for patients (Stinchfield, 2008). According to the CDC (2009), one of the most
profound factors influencing vaccine uptake was attitudes. In one particular study,
attitudes of both the patient and provider were examined before a visit as the percentage
of patients immunized during the visit were measured. An increase in patients
immunized, nearly 90%, were noted when the patient and provider had positive attitudes
toward vaccination (CDC, 2009). Upon recommendation of immunization by the
provider, approximately 70% of the patients opted to receive the vaccine. In the cases
where the provider did not recommend immunization, only 8% of the patients opted for
immunization (CDC, 2009). That being said, it is clear that providers must advocate for
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vaccination as it can aid in combating patients negative attitudes and opinions towards
vaccination.

15
Section 3: Methodology
Project Design and Methods
Using a specific primary care practice, located in a community outside of New
York City, potential participants were approached and invited to take part in the survey.
This was done in person, after they had received their medical care and left the exam
room. When they agreed to participate, they were taken to a private room to complete the
survey.
The survey (Appendix A) consisted of questions geared towards ascertaining
current influenza immunization status and reasons for refusal. Ethical approval for this
project was obtained from the appropriate parties at the facility where the evaluation was
conducted as well as the Walden University Institutional Review Board. Written consent
(Appendix B) was ascertained from participants meeting the requirements as well.
An educationally planned module, based on responses to the survey, was then
developed. This educational module was aimed at increasing awareness on vaccination
barriers to healthcare providers as well as patients, and ways to successfully address
them.
Population
Improving influenza vaccine uptake among adults 65 and older in any community
is essential. According to the United States Census Bureau, the demographics of this
specific area included in this survey depicts a largely White (78%), African American
(13%), and Hispanic (7%) population (United States Census Bureau, 2014). This report
also specified that of the 472,621 people living in this area, 14% are 65 years and older
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(United States Census Bureau, 2014). Calculating the percentages, this would constitute
a population of 66,167 people over the age of 65 in this community.
Based on these demographics and with a predominance of this population
speaking English, written materials were presented in the English language with the
option of translating into Spanish if needed. One hindrance for healthcare providers
regarding the anticipatory necessities for influenza vaccine uptake is that public views on
influenza risk concerning the seasonal vaccine changes from year to year. Moreover,
influenza strains can be different from year to year, causing increases in the severity of
illness it can cause as well as how quickly it can spread.
According to the CDC, 2014 was a very critical and difficult year as only 23% of
the influenza vaccine was shown to be effective (CDC, 2014). Normally, the influenza
vaccine has shown to prevent 60 to 65% of serious infections. However, it has been
noted that the 2014 season’s influenza vaccine is less effective because the viruses used
in making the vaccine did not match with the viruses that spread throughout the United
States (CDC, 2014). In order for the manufacturers to have ample time to produce the
vaccines, scientists must select the viruses used for the vaccines in the spring. In 2014,
however, it was noted by scientists that influenza A (H3N2), which happens to be the
dominant strain in circulation, started mutating immediately. As a result, approximately
68% of these viruses "drifted" to be altered genetically from the influenza viruses used in
making the vaccines (CDC, 2014).
Eligible participants in the study consisted of a population group who did not, for
whatever reason, receive the flu vaccine. I also isolated subjects to the adult population
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of 65 years and older within the primary practice I currently use for my practicum
experience. A discussion and generic form was implemented to explore in a structured
manner what factors towards influenza vaccination behavior the participants experienced.
The structure of the discussion and form was based on the HBM, as it provided a
theoretical framework for gaging the likelihood that an individual will use suggestions
and recommendations available to them.
Project Evaluation Plan
A program evaluation is an ongoing process that begins during program
development (Hodges & Videto, 2011). However, evaluation for the sake of evaluation
is not enough as valid conclusions and meaningful results need to be made for improved
programs. Since the project was aimed at looking to create an educational program to
potentially increase influenza vaccine uptake, gain knowledge, and change behavior, a
summative evaluation design was used. Summative evaluation is a broad term referring
to an evaluation that is conducted for the purpose of determining whether a program
worked (Hodges & Videto, 2011). This type of evaluation focuses on whether or not the
program produced its intended effects (Hodges & Videto, 2011). It is an external method
of judging the worth of a program at the end of the program that also focuses on the
outcome.
When planning and developing extension programs, the first stage consists of a
needs assessment. It is important to distinguish between needs, wants, and interests when
needs are being determined. For example, needs refers to something regarded as required
or to achieve a purpose. Wants, conversely, are seen as desirable or useful, but not
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required. Interests specify an individual's interest or curiosity about something. It is
therefore not uncommon for individuals to mistake needs, wants, and interests. Hence, to
certify an understanding for all vested parties, involvement of the target population is
necessary.
It is important for representatives of the target population as well as stakeholders
to be involved in developing the goals and objectives for the program to ensure an
understanding for all involved. For example, allowing the representatives from the target
population to aid in data collection techniques provides a sense of involvement and
inclusion. Some of these methods include face-to-face interviews, strategic interviews,
questionnaires, and casual observations as well as formal observations. To prevent
unfavorable results, representatives from whom the needs assessment data are collected
should not intermingle with one another during the course of gathering data
Involvement of the target population and stakeholders in developing goals and
objectives ensures an understanding for all involved. Stakeholders are considered to be
those involved in program undertakings. Some examples would be administrators,
managers, sponsors, funding officials, collaborators, and staff. In this case, they would
include principle physicians included in the practice, the general manager, staff, and
those affected by the program (e.g., clients and family members) as well as primary users
of the evaluation.
Stakeholder involvement fosters input, contribution, and influence among those
who may have an investment in the oversight of the evaluation and findings. Engaging
and involving stakeholders also helps to amplify the chances that the evaluation will be
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useful, can improve credibility, can refine roles and responsibilities, can aid in protecting
participants, and can avoid both real and or perceived conflicts of interest.
Educators and developers of a planned program rely on an evaluation tool that
will help them to be accountable for their programs, demonstrate the impacts of their
programs, and pinpoint improvements in their programs. By assessing outcomes
resulting from dissemination of educational strategies, materials, and products, I will be
able to determine in what ways the distribution of the program has benefited the target
population and in what ways the program has directly been applied and utilized in their
personal lives. The evaluation plan consisted of a participation evaluation tool including
simple questions entailing short responses with a final question regarding suggestions for
improvements.
Data Analysis
As stated earlier, there is little knowledge of the reasoning underlying decisions
about flu vaccine behavior among the elderly. Therefore, the information retrieved from
these surveys were reviewed and investigated. Frequencies of responses were evaluated
and documented to apply towards the educational planned program. Common themes
were closely monitored, as this will greatly benefit the scheme of the educational
program.
A sample size of 50 participants was noted. This included 32 females and 18
males. All participants were over the required 65 years of age. Of the 32 females, 28
stated to be of White race and four African Americans. Of the 18 males, 14 were White
and four were African American. All participants stated that English was their primary
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language. Common themes and trends were examined and recorded. Of the 50
participants, 45 (all 32 females and 13 males) stated they refused the influenza vaccine
due to fear of getting the flu from the vaccine itself. The remaining five (all males) stated
they never got the flu and therefore do not feel they needed the vaccine.
Summary
Despite the fact that people considered to be in the older population are entitled to
free flu vaccinations, the vaccination receiving rate among this population is lacking. A
number of theories and models offer explanations and predictions around whether people
will seek or accept health interventions. Application of these theories may assist health
professionals to develop strategies to help patients in making informed decisions. Health
professionals need to use their knowledge and consultation skills to understand relevant
aspects of health psychology and to apply them in a therapeutic manner. They must also
elicit their patients’ ideas, concerns, and expectations about the flu vaccine. By
evaluating potential barriers and providing educational tools to overcome those barriers,
the older adult population receiving the flu vaccine may increase, therefore reducing the
incidences of influenza and its associated complications.
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Section 4: Findings, Discussion, and Implications
Evaluation and Discussion of Findings
Upon reviewing survey responses, it was apparent that most barriers or reasons
stated, from a strong majority of the participants, were related to fear of becoming ill
from the vaccine. When reviewing the data from the survey, most barriers appear to be
related to a patient’s fear of getting sick from the vaccine. According to Weise & Szabo
(2013), many people possess this logic that receiving the influenza vaccine can actually
give the person the influenza virus. In fact, one such survey by CVS Pharmacy conducted
in 2013 concluded that approximately 35% of consumers thought this to be true (Weise &
Szabo, 2013). That being said, this reasoning, or barrier, proved to be the prime directive
to address towards overcoming an individual’s fear of vaccination and therefore further
evaluation of the vaccine itself was warranted.
Upon review of the chemical components of the vaccine itself, professor Charles
Chu, a leading professor of infectious disease at the University of California-San
Francisco, stated that there is a chemical inactivation used to kill and generate an inactive
and noninfectious outcome of the influenza virus (Weise & Szabo, 2013). Sufficient
amounts of the outer coating of the virus remains intact enough to elicit a more hearty
and dependable immune response within the body that is entirely incapable of
reproducing (Weise & Szabo, 2013). Some people may develop mild body aches,
fatigue, muscle pain, and a low fever, "but it's very rare and it's not due to flu. It's the
body's immune response" kicking in, Chiu stated. The symptoms are "very mild and
typically go away in a day or so” (Weise &Szabo, 2013). It is more probable that anyone
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receiving the vaccine developed a different kind of respiratory infection and not
influenza. Since the process of an immune response takes 14 days after vaccination, it is
also likely that the immune system did not have enough time to defend itself against this
invading agent (Weise & Szabo, 2013).
The CDC (2014) has also reported that influenza vaccines are safe and are unable
to give someone influenza since the vaccine is made from an attenuated virus. However,
there may be some slight side effects as there are two different kinds of vaccines, a nasal
spray and injectable vaccine. Most common side effects noted from the influenza
vaccine can include redness, soreness, and discomfort or swelling at the site of injection
(CDC, 2014). Furthermore, side effects noted from the nasal spray include runny nose,
cough, or nasal congestion. In fact, in a randomized blinded study where some
participants received influenza vaccines and others received saltwater injections, the only
difference in symptoms noted was increased soreness in the arm and redness at the
injection site among people who received the influenza vaccine, according to the CDC
(2014). Interestingly, there were no distinctions in regards to body aches, fever, cough,
runny nose, or sore throat.
Vaccination still remains the single most important action one can take for the
protection and prevention of influenza. Ultimately, if people have received the influenza
vaccine, they can assume a 62% reduction in the possibility of contracting influenza. On
the other hand, they have a 0% protection rate if vaccination was not received.
Therefore, health providers must urge not to let the odds stop the patient from getting
vaccinated, especially for high risk populations.
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Implications for Practice
As stated earlier, considerable improvement in yearly influenza vaccination of
recommended and high risk groups is warranted to reduce the health consequences of
influenza and aid in reaching one of the goals set forth by Healthy People 2020 of
enlarging the number or children and adults vaccinated annually for seasonal influenza
(CDC, 2014). Despite being universally recommended, especially in the elderly, some
patients are not requesting the vaccine and healthcare providers are not encouraging
them. Some on health care providers may not be aware of their patient’s vaccination
status and are therefore missing opportunities during office visits to update their status.
Other health care provider’s may allow their personal views towards vaccination to
impede into practice. There are health care providers who feel that although the
government, the CDC and providers mean well and may have done their due diligence,
the influenza vaccine remains ineffective and may even cause illness (Brogan, 2013). If
an individual’s health care provider harbors these feelings, despite current research
regarding the chemical components and proven effectiveness, they are less likely to
encourage vaccination. This may indirectly affect the attitudes and beliefs of patients
regarding the flu vaccine and hinder their decision to accept vaccination. Although the
majority of responses to the survey in question related to participants fears of becoming
ill from the vaccine and not on attitudes and opinions of the provider, it is worth
mentioning since it is noted in the literature and this was a small sample size and may not
reflect the opinions of a larger population.
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When evaluating systems that have successfully reduced vaccine disparities, such
as the Veteran’s Affairs Healthcare System (VA), we see they have shifted the focus on
what happens during the patient’s visit with the healthcare provider to ensure that the
opportunity for education and ultimately vaccination does not get missed (American
Lung Association, 2010). Electronic medical records, automated reminders and
permitting non-physician, yet qualified, personnel to administer vaccines are all system
changes the VA has implemented to increase the probability of vaccines being
administered (American Lung Association, 2010).
Within the primary care setting, the widest scope of health care variations are
noted. Therefore, patients ranging in age, socioeconomic and geographic origins, those
seeking to sustain optimal health, and those affected with acute and chronic physical,
emotional, and social health issues are embodied within this type of setting. Practitioners
within this role play an important part in health promotion, especially primary prevention
vaccination. Strategies for improving health and engaging patients to nourish their own
health are also important responsibilities of the primary provider.
Upon review of the literature, certain facts remain and are identified by
researchers to disprove popular beliefs regarding nonvaccination. According to a report
from the American Lung Association (2010), research has indicated the elderly
population will more likely accept the healthcare provider’s recommendation for
vaccination once a stable and trusting relationship between patient and healthcare
provider has been established. Results from this project yielded an informational tool
(Appendix C) designed for implementation into practice to target barriers and assist
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health care providers when faced with reasons for refusal or when educating patients on
the importance of vaccination. This may also be beneficial when questioning one’s own
values and beliefs regarding vaccination as the health care provider’s role is influential.
Above all, it is important for providers to convey information regarding vaccines at every
encounter as they remain the most cost-effective clinical preventive services and are a
core component of any primary care practice.
Project Strengths and Limitations
In this project, details about human behavior, emotion, and personalities were
examined. This included information regarding behaviors, desires, and assumptions. It is
assumed that within a study, there will be some factors outside of the investigator’s
control. Following data collection, rather than performing a statistical analysis,
descriptive trends were examined. As a result of utilizing descriptive analysis, which
permits understanding behaviors of values, beliefs, and assumptions; a project strength
can be noted. In reviewing life experiences and beliefs of another individual when
exercising this technique, one can often remove the barriers of influence the researcher
may impose.
Limitations noted were that the survey was dependent on conditions occurring
during the period of time the surveys were conducted. Participants of this survey
answered honestly, according to them; however, this may not be true. It was also
impossible to include everyone over the age of 65 within this community; therefore, the
sample can only be assumed to have represented the chosen population and can only be
suggested to a larger population.
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Research bias may also play a factor as well. Participants may feel the need to
convey to the researcher what they think the researcher wants to know. This may be
especially difficult if the researcher is a health care provider, especially if they harbor
negative attitudes towards vaccination that they may not want to disclose. Other
limitations to mention include time constraints, willingness to participate, small sample
size, location, and population size of practice.
Analysis of Self
Part of the evidence based practice process is understanding how to apply the
knowledge that is already published in the literature and use this information to solve a
problem (Mauk, 2012). In the case of this project; barriers to receiving the influenza
vaccine in adults > 65, the researcher chose a topic with ample information and research
available regarding the influenza vaccine itself; however, how to overcome barriers to
receiving the vaccine to aid health care providers was minimally noted. As a healthcare
provider it is not only valuable to be aware of possible barriers but to possess the
knowledge on how to overcome these barriers. Although education is widely available
to consumers and healthcare providers that does not guarantee that appropriate
procedures in practice will be utilized. For example, at times providers may have
difficulties in determining how, when and what practices to employ for the management
of vaccination administration and overcoming barriers, even under the best of
circumstances. Depending on the barrier in question the appropriate, effective and best
practice would then be selected. This project was intended to assist all health care
providers and patient’s faced with the challenge of vaccination barriers in the future.
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Professional and educational development in nursing helps nurses see issues from
different perspectives, to value their contributions to the profession, and to respect the
work done by colleagues both within nursing and in other disciplines that contribute to
quality patient care (DeSilets & Dickerson, 2010). By completing this project, the
researcher has realized that as an advanced practice nurse can provide knowledge and
clinical research outcomes to be brought into everyday use. A DNP possesses the skills
and knowledge to utilize information available into a useful and workable form that can
be used to guide health care providers, thus improving patient outcomes.
As a scholar, development of this project afforded the researcher the means to
study, analyze and comprehend a subject matter they may not have been previously
considered. As a practitioner, the experience and findings of this project are instrumental
and contributory towards the inception of a DNP career and practice aimed at improving
patient outcomes. As a professional, future endeavors will benefit from the selfawareness discovered from this overall experience.
Summary
As stated earlier, adults 65 years and older typically account for more than half
(60%) and almost all (90%) flu-related deaths and with the aging U. S. population
increasing in the next several decades it is concerning that these numbers will
dramatically increase. The impact that influenza has on our society in regards to medical
costs, loss of productivity and lost lives is equally concerning. One of the notions of
public health is that it is beneficial to prevent disease than to have to treat it. The power
of prevention is vital as are the revelations regarding myths of vaccination. It is crucial
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to recognize the disparities that exist resulting from lack of awareness and effective
measures surrounding barriers to vaccination. Without this realization we cannot move
forward and progress in a more effective direction.
Despite a patient’s resistant attitude towards vaccination, a healthcare provider’s
recommendation to vaccinate has a strong influence in a patient’s decision making
process. However despite the evidence that a large majority of patients will receive the
vaccine once recommended by the healthcare provider, many healthcare providers are not
routinely recommending the vaccine to their adult patients (American Lung Association,
2010). With an unknown knowledge of the severity each influenza season will bring it is
vital to remain current and consistent with governing bodies and recommendations.
Frieden, director of the CDC stated that "though we cannot predict what will happen the
rest of this flu season, it's possible we may have a season that's more severe than most,"
regarding the 2014 influenza season (CDC, 2014). Officials from the CDC remained
certain that the influenza vaccine should provide some protection and still advised people
to get vaccinated (CDC, 2014). It continues to be the responsibility of health care
providers to educate patients and the community on the flu vaccine and to continue to
recommend it.
Barriers relating to decreasing vaccination rates are not impossible to overcome.
It remains the health care provider’s obligation to exercise their knowledge and
consultation skills to understand relevant aspects of health psychology and to apply them
in a therapeutic manner when attempting to overcome such barriers. They must also
elicit their patients’ ideas, concerns, and expectations about the flu vaccine. By
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evaluating potential barriers and providing educational tools to overcome those barriers,
the older adult population receiving the flu vaccine may increase, therefore reducing the
incidences of influenza and its associated complications. It is ultimately the aim of this
project to aid in this challenge as well.
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Section 5: Scholarly Product
Many people in the United States each year are hospitalized from flu-related
illness. Adults 65 years and older typically account for more than half of these
hospitalizations and almost all flu-related deaths. Vaccination can be regarded by many
as the most effective means of reducing influenza infection. In this project, barriers to
receiving the influenza vaccine among the 65 and older population in a community
setting were identified and interventions to eliminate unnecessary barriers are proposed.
The question of, “For patients 65 years and older, what are potential barriers to receiving
the influenza vaccine?” was examined. Patients meeting the criteria for inclusion
completed a survey, and the results were evaluated. Evaluating potential barriers and
providing educational tools to overcome those barriers, thus increasing the older adult
population in receiving the influenza vaccine, may reduce the incidences of influenza and
its associated complications. For the benefit of implications into practice, a fact sheet
(Appendix C) has been developed and is provided to target this barrier for the benefit of
health care providers when faced with this reason for refusal when discussing vaccination
with patients. Above all, it is important for providers to convey important information
regarding vaccines as they still remain the most cost-effective clinical preventive services
and are a core component of any primary care practice.
A Doctor of Nursing Practice nurse has the potential to develop and improve
evidence based practice at the local, state and national level. Addressing barriers related
to receiving the influenza vaccine in adults over 65 years old for possibility of becoming
a change agent and positively affecting the masses was the intent of this project. As a
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result, the focus on providing leadership for evidence based practice and translating
research into practice remains to be one of the goals of the DNP. This requires
competence, decision-making, evaluating research and evidence as well as
implementation of findings.
Creating a meaningful contribution into practice and policy was also an objective
of this project. To have the ability to positively affect practice and policy is a privilege
afforded to the DNP. This process served not only as a learning experience but as a
guide aimed at demonstrating the DNP student’s ability to apply systemic inquiry into a
specific need in healthcare practice. In order to apply these finding’s into practice, it is
the intention of the researcher to provide the educational tools developed not only to the
practice setting but to disseminate into the community as well thru local programs and
healthcare facilities. Educational tutorials and seminars for patients, community and
healthcare providers will be conducted at local primary care settings and healthcare
facilities upon approval from appropriate administration.
To be more specific, in the local area where the research took place, there are 7
clinics separately located in various facilities that offer’s assistance, information and
administration of the influenza vaccine if desired. These clinics are state operated and
are also free to the public. The near future plan is to present and distribute project
findings and educational tools at these community sites to engage and further educate the
community regarding the importance of accepting the seasonal flu vaccine. It is also the
intent of the researcher to engage the health care community through a speaking
engagement at a local conference, pending approval, where the importance of seasonal
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and recommended vaccinations will be discussed. Through program evaluation and
distribution, it is a goal to encourage positive social change and attitudes of individuals
and communities to improve human and social conditions related to the importance of
influenza vaccination.
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Appendix A: Influenza Vaccine Survey
2015

Please circle the answer that best applies to you:

1.

Have your received the influenza vaccine this year?

2.

What is your gender?

3.

How old are you?

4.

What is your race/ethnicity (optional)?

5.

What is your primary language? English

6.

Please list your reasons for NOT receiving the influenza vaccine?

M

65-75

Yes

No

F

76-85

86-95

>96

Spanish

Other
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Appendix B: Consent Form

You are invited to take part in a research study of Barriers to receiving the Influenza
vaccine. The researcher is inviting Adults 65 years and older not receiving the Influenza
vaccine to be in the study. This form is part of a process called “informed consent” to
allow you to understand this study before deciding whether to take part. This study is
being conducted by a researcher named Melissa Madalone, who is a doctoral student
Walden University. You may already know the researcher as a Nurse Practitioner, but
this study is separate from that role.
Background Information:
The purpose of this study is to evaluate barriers to receiving the Influenza vaccine.
Procedures:
If you agree to be in this study, you will be asked to complete a survey that asks some
general demographic information such as your age and gender and what your reason(s)
are for not getting the influenza vaccine. The survey will take about five minutes to
complete and there are no risks involved. There are no thank you gift(s), compensation, or
reimbursements involved.
Voluntary Nature of the Study:
This study is voluntary. Everyone will respect your decision of whether or not you
choose to be in the study. No one at will treat you differently if you decide not to be in
the study. If you decide to join the study now, you can still change your mind later. You
may stop at any time and your decision to participate or not, will have no impact on your
ability to receive services with this clinic. There is a potential benefit of learning how to
reduce the spread of an Influenza epidemic.
Privacy:
Any information you provide will be kept confidential. The researcher will not use your
personal information for any purposes outside of this research project. Data will be kept
secure by locked access. Data will be kept for a period of at least 5 years, as required by
the university.
Contacts and Questions:
You may ask any questions you have now. Or if you have questions later, you may
contact the researcher via. If you want to talk privately about your rights as a participant,
you can call Dr. Leilani Endicott. She is the Walden University representative who can
discuss this with you. Her phone number is 612-312-1210. Walden University’s approval
number for this study is IRB will enter approval number here and it expires on IRB
will enter expiration date. You may keep this consent forms.
Statement of Consent:
I have read the above information and I feel I understand the study well enough to make a
decision about my involvement. In order to maintain privacy, signatures are not required
and completion of the survey will indicate consent.
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Appendix C: Influenza Vaccine Fact Sheet

FACT:
The influenza vaccine CANNOT give you the flu because they
are
made in two ways:
Flu vaccine viruses that have been 'inactivated' and are not infectious*
Or
With no flu vaccine viruses at all (as in recombinant influenza vaccine)*

Millions of seasonal flu vaccines have been given safely*
Vaccination is the single most important step you can take to protect
yourself

Not getting vaccinated means you have 0% protection

It’s safe to vaccinate!
Centers for Disease Control (CDC) (2014). 2014-2015 Seasonal Influenza Vaccine Safety.
Available from http://www.cdc.gov/flu/protect/vaccine/general.htm

